Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Michael W. Weiner, Dallas P. Veitch, Paul Aisen, et al.
Alzheimer s & Dementia (2015) Vol. 11, Iss. 6
Open Access | Times Cited: 298

Showing 1-25 of 298 citing articles:

A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages
Saima Rathore, Mohamad Habes, Muhammad Aksam Iftikhar, et al.
NeuroImage (2017) Vol. 155, pp. 530-548
Open Access | Times Cited: 549
Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies
Borislav Dejanovic, Melanie A. Huntley, Ann De Mazière, et al.
Neuron (2018) Vol. 100, Iss. 6, pp. 1322-1336.e7
Open Access | Times Cited: 399
Common polygenic variation enhances risk prediction for Alzheimer’s disease
Valentina Escott‐Price, Rebecca Sims, Christian Bannister, et al.
Brain (2015) Vol. 138, Iss. 12, pp. 3673-3684
Open Access | Times Cited: 396
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative
Dallas P. Veitch, Michael W. Weiner, Paul Aisen, et al.
Alzheimer s & Dementia (2018) Vol. 15, Iss. 1, pp. 106-152
Closed Access | Times Cited: 395
The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement
Michael W. Weiner, Dallas P. Veitch, Paul Aisen, et al.
Alzheimer s & Dementia (2016) Vol. 13, Iss. 5, pp. 561-571
Open Access | Times Cited: 372
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials
Michael W. Weiner, Dallas P. Veitch, Paul Aisen, et al.
Alzheimer s & Dementia (2017) Vol. 13, Iss. 4
Open Access | Times Cited: 271
NPTX2 and cognitive dysfunction in Alzheimer’s Disease
Mei-Fang Xiao, Desheng Xu, Michael T. Craig, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 265
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk, Peter Riederer, Sid E. O’Bryant, et al.
The World Journal of Biological Psychiatry (2017) Vol. 19, Iss. 4, pp. 244-328
Open Access | Times Cited: 257
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
Michael W. Weiner, Dallas P. Veitch, Paul Aisen, et al.
Alzheimer s & Dementia (2015) Vol. 11, Iss. 7, pp. 865-884
Open Access | Times Cited: 221
A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal magnetic resonance imaging data
Hongming Li, Mohamad Habes, David A. Wolk, et al.
Alzheimer s & Dementia (2019) Vol. 15, Iss. 8, pp. 1059-1070
Open Access | Times Cited: 208
Longitudinal ComBat: A method for harmonizing longitudinal multi-scanner imaging data
Joanne C. Beer, Nicholas J. Tustison, Philip A. Cook, et al.
NeuroImage (2020) Vol. 220, pp. 117129-117129
Open Access | Times Cited: 192
Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease
Edward J. Goetzl, Erin L. Abner, Gregory A. Jicha, et al.
The FASEB Journal (2017) Vol. 32, Iss. 2, pp. 888-893
Open Access | Times Cited: 186
Biomarkers for the Early Detection and Progression of Alzheimer's Disease
Scott Counts, Miloš D. Ikonomović, Natosha M. Mercado, et al.
Neurotherapeutics (2016) Vol. 14, Iss. 1, pp. 35-53
Open Access | Times Cited: 180
The cellular model for Alzheimer's disease research: PC12 cells
Danni Xie, Ting Deng, Zhenwei Zhai, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 15
Open Access | Times Cited: 47
Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases
Kira Sheinerman, Jon B. Toledo, Vladimir Tsivinsky, et al.
Alzheimer s Research & Therapy (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 158
Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy
Robert A. Stern, Yorghos Tripodis, Christine M. Baugh, et al.
Journal of Alzheimer s Disease (2016) Vol. 51, Iss. 4, pp. 1099-1109
Open Access | Times Cited: 152
Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline
Shannon L. Risacher, Wesley H. Anderson, Arnaud Charil, et al.
Neurology (2017) Vol. 89, Iss. 21, pp. 2176-2186
Open Access | Times Cited: 143
Feature-ranking-based Alzheimer’s disease classification from structural MRI
Iman Beheshti, Hasan Demirel
Magnetic Resonance Imaging (2015) Vol. 34, Iss. 3, pp. 252-263
Closed Access | Times Cited: 120
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
Niklas Mattsson, Anders Lönneborg, Marina Boccardi, et al.
Neurobiology of Aging (2017) Vol. 52, pp. 196-213
Closed Access | Times Cited: 110
Molecular and cellular pathophysiology of preclinical Alzheimer’s disease
Elliott J. Mufson, Miloš D. Ikonomović, Scott Counts, et al.
Behavioural Brain Research (2016) Vol. 311, pp. 54-69
Open Access | Times Cited: 108
PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases
Zhengxin Cai, Songye Li, David Matuskey, et al.
Neuroscience Letters (2018) Vol. 691, pp. 44-50
Open Access | Times Cited: 108
Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
Lih‐Fen Lue, André Guerra, Douglas G. Walker
Neurology and Therapy (2017) Vol. 6, Iss. S1, pp. 25-36
Open Access | Times Cited: 107
Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals
Duygu Tosun, Susan Landau, Paul Aisen, et al.
Brain (2017) Vol. 140, Iss. 5, pp. 1499-1512
Open Access | Times Cited: 100
Genetic architecture of Alzheimer's disease
Sarah M. Neuner, Julia TCW, Alison Goate
Neurobiology of Disease (2020) Vol. 143, pp. 104976-104976
Open Access | Times Cited: 99
Repetitive head impact exposure and later‐life plasma total tau in former National Football League players
Michael L. Alosco, Yorghos Tripodis, Johnny Jarnagin, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2016) Vol. 7, Iss. 1, pp. 33-40
Open Access | Times Cited: 94
Page 1 - Next Page

Scroll to top